As of 2024-12-13, the EV/EBITDA ratio of VBI Vaccines Inc (VBIV) is -0.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VBIV's latest enterprise value is 0.01 mil USD. VBIV's TTM EBITDA according to its financial statements is -45.59 mil USD. Dividing these 2 quantities gives us the above VBIV EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 17.0x | 16.0x |
| Forward P/E multiples | 15.4x - 21.2x | 15.7x |
| Fair Price | (3,197.08) - (3,520.94) | (3,290.50) |
| Upside | -4896081.3% - -5392037.9% | -5039145.7% |
| Date | EV/EBITDA |